iRay Group (SHA:688301)
China · Delayed Price · Currency is CNY 126.57
+1.37 (1.09%)
At close: Mar 6, 2026
iRay Group Market Cap
iRay Group has a market cap or net worth of 26.73 billion as of March 6, 2026. Its market cap has increased by 84.41% in one year.
Market Cap
26.73B
Enterprise Value
27.12B
Revenue
2.30B
Ranking
n/a
PE Ratio
38.35
Stock Price
126.57
Market Cap Chart
Since September 18, 2020, iRay Group's market cap has increased from 11.61B to 26.73B, an increase of 130.16%. That is a compound annual growth rate of 16.48%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 5, 2026 | 26.44B | 23.80% |
| Dec 31, 2025 | 21.36B | 56.41% |
| Dec 31, 2024 | 13.66B | -58.82% |
| Dec 29, 2023 | 33.16B | -0.38% |
| Dec 30, 2022 | 33.28B | -7.67% |
| Dec 31, 2021 | 36.05B | 189.42% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Sep 18, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Imeik Technology Development | 41.60B |
| Gan & Lee Pharmaceuticals. | 36.94B |
| Intco Medical Technology | 29.85B |
| Zhende Medical | 23.67B |
| Andon Health | 21.41B |
| Winner Medical | 19.64B |
| Shenyang Xingqi Pharmaceutical | 16.97B |
| Autek China | 13.56B |